Glory Star Provides Authorization to E-Surfing Media to Launch CHEERS Video Series
BEIJING, Sept. 08, 2020 (GLOBE NEWSWIRE) — Glory Star New Media Group Holdings Limited (NASDAQ: GSMG) (“Glory Star” or the […]
BioCryst to Present at 22nd Annual H.C. Wainwright Global Investment Conference
RESEARCH TRIANGLE PARK, N.C., Sept. 08, 2020 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company will […]
LGI Homes Introduces New Floor Plan Lineup With New Community in Tucson
TUCSON, Ariz., Sept. 08, 2020 (GLOBE NEWSWIRE) — LGI Homes, Inc. (Nasdaq:LGIH) announced a lineup of five new floor plans at […]
KLX Energy to Participate in the Barclays CEO Energy-Power Virtual Conference
HOUSTON, Sept. 08, 2020 (GLOBE NEWSWIRE) — KLX Energy Services Holdings, Inc. (Nasdaq: KLXE) (“KLXE” or the “Company”) announced that […]
BeyondSpring Receives Breakthrough Therapy Designations from Both U.S. FDA and China NMPA for Plinabulin in Chemotherapy-Induced Neutropenia Indication
– FDA Breakthrough Designation for CIN Indication: Plinabulin for Concurrent Administration with Myelosuppressive Chemotherapeutic Regimens in Patients with Non-Myeloid Malignancies […]
Rosehill Resources Inc. and Rosehill Operating Company, LLC Emerge from Chapter 11
HOUSTON, Sept. 08, 2020 (GLOBE NEWSWIRE) — Rosehill Resources Inc. (“RRI”) and Rosehill Operating Company, LLC (“Rosehill Operating” and together […]
Evelo Biosciences to Participate in Upcoming Investor Conferences in September
CAMBRIDGE, Mass., Sept. 08, 2020 (GLOBE NEWSWIRE) — Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a new […]
Aravive to Participate in Upcoming Virtual Investor Conferences in September
HOUSTON, Sept. 08, 2020 (GLOBE NEWSWIRE) — Aravive, Inc. (Nasdaq: ARAV), a clinical-stage oncology company developing transformative therapeutics, today announced […]
Progress Announces Preliminary Fiscal Third Quarter 2020 Financial Results and Updated Full Year 2020 Guidance
BEDFORD, Mass., Sept. 08, 2020 (GLOBE NEWSWIRE) — Progress (NASDAQ: PRGS), the leading provider of application development and digital experience […]
Strongbridge Biopharma plc Announces Positive and Statistically Significant Top-Line Results from the Pivotal Phase 3 LOGICS Study of RECORLEV® (levoketoconazole) for the Treatment of Endogenous Cushing’s Syndrome
~ LOGICS Study Met Primary Endpoint with High Statistical Significance; Results at the End of the Randomized-Withdrawal Phase of the […]
